TP53 mutations are present in various human cancers (pancreatic adenocarcinoma, liver hepatocellular carcinoma, chromophobe renal cell carcinoma, acute myeloid leukemia, thymoma, etc.)and represent potential prognostic markers (37). This evidence concerns the gene TP53 and acute myeloid leukemia.